ExL (Digital Pharma East 2012)

Share this article:

MM&M Executive Editor, Marc Iskowitz, catches up with Bryon Main, Principal and Founder of ExL Pharma, to discuss the changing industry landscape and the evolution of digital. Sponsored content

 

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Agency

Five things for pharma marketers to know: Monday, October 20, 2014

Five things for pharma marketers to know: Monday, ...

Suit alleges Purdue's OxyContin turned eastern Kentucky into "Wild West"; AbbVie-Shire $1.6B break-up fee could be tax write-off; Lilly CEO tells WSJ that 2014 has been "toughest year."

Cadient acquired by tech co. Cognizant

Cadient acquired by tech co. Cognizant

In an estimated $30-million deal, Pennsylvania healthcare comms agency Cadient Group is to be acquired by tech consultancy Cognizant.

Five things for pharma marketers to know: Wednesday, October 8

Five things for pharma marketers to know: Wednesday, ...

Cadient is being acquired by consultancy Cognizant; Valeant ups the ante in Allergan bid; BMS settles Sustiva patent suits; Americans are dying at a lesser rate; Stricter Ebola screening at ...